Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Mar 24.
Published in final edited form as: Chemistry. 2016 Feb 24;22(14):4748–4752. doi: 10.1002/chem.201600191

NHC-Pd(II) Catalyzed Methylene C(sp3)–H Arylation of Piperidines and Tetrahydropyrans

Shengqing Ye †, Weibo Yang †, Timothy Coon §, Dewey Fanning §, Tim Neubert §, Dean Stamos §, Jin-Quan Yu †,✉
PMCID: PMC4805524  NIHMSID: NIHMS688315  PMID: 26841330

Abstract

Pd(II)-catalyzed C(sp3)–H arylation of saturated heterocycles with a wide range of aryl iodides has been achieved using a N-heterocyclic carbene (NHC) ligand, thus demonstrating the compatibility of carbene ligands in a Pd(II)/Pd(IV) catalytic manifold. This arylation method provides a new approach towards further diversifying pharmaceutically relevant piperidine and tetrahydropyran ring systems.

graphic file with name nihms688315u1.jpg


In the past decade, a wide range of Pd(II)-catalyzed β-C–H functionalization reactions of aliphatic acids have been developed using directed C–H activation.1 Our early studies demonstrated excellent stereocontrol in β-C–H functionalizations using a chiral oxazoline as the auxiliary.2 The use of amino-quinoline bisdentate directing groups has proven to be exceptionally effective for methylene C–H arylation.3 Towards the ultimate goal of achieving simple and practical β-C–H funtionalization reactions, we have developed a number of weakly coordinating directing groups.4 While these directing groups are highly efficient for the activation of C(sp2)–H4a,c,e,f and primary C(sp3)–H4b,4d bonds, poor reactivity in methylene C–H activation has been observed. Recently, the discovery of a series of pyridine and quinoline ligands has enabled methylene C–H activation using these simple weakly coordinating directing groups.5 Herein we demonstrate that N-heterocyclic carbenes, as another class of σ-donor ligands,6 can promote Pd(II)-catalyzed methylene C–H arylation. Notably, this protocol is compatible with medicinally important piperidines and tetrahydropyrans.

Piperidine and tetrahydropyran motifs are widespread among drug molecules.7 An analysis of all launched drugs within the Integrity database shows approximately 320 registered drugs containing saturated piperidines and approximately 130 containing saturated tetrahydropyrans (THP’s). When one eliminates natural product-based drugs from the analysis (where the piperidine moiety derives from biosynthetic processes and carbohydrate based THP derivatives) the remaining ~260 piperidines are mostly derived from simple commodity chemicals: un-substituted piperidine itself and all regioisomers of piperidone and piperidine carboxylic acids.8 A similar conclusion can be drawn for the approximately 10 non-carbohydrate derived THP-based drugs.8 We envisage that directed C–H arylation of readily available piperidine or tetrahydropyran building blocks with wide range of aryl iodides could rapidly expand the diversity of these molecules. Despite the significant progress in sp3 C H arylation, arylation of piperidines and tetrahydropyrans at the C-3 and C-4 remains a significant challenge.9–13

Our recent finding that pyridine and quinoline ligand type mono-dentate σ-donor ligands can significantly accelerate sp3 C H functionalization of amide substrates5 prompted us to investigate whether the readily available NHC ligands could be harnessed to promote C–H arylation via Pd(II)/Pd(IV) catalysis. Although a Pd(0)/NHC-catalyzed intramolecular enantioselective C(sp3)–H arylation via Pd(0)/Pd(II) redox has been demonstrated in pioneering studies,14,15 the feasibility of NHC ligands to promote intermolecular C(sp3)–H arylation remains to be demonstrated.16 Thus, the development a NHC-promoted C(sp3)–H arylation reaction of piperidines and tetrahydropyrans is of fundamental importance to catalysis in addition to being useful in medicinal chemistry. Our recent success in developing a number of Pd(II)-catalyzed C–H arylations of amides enabled by mono-dentate σ-donor ligands led us to focus on the use of Pd(II) catalysts. Guided by the need for diverse piperidines in medicinal chemistry, we began to develop β-arylation of amide 1a derived from 2-piperidinecarboxylic acid (Table 1). We found that reacting 0.1 mmol of amide 1a with 2.0 equiv of aryl-iodide 2a in the presence of 10 mol% of Pd(TFA)2, 20 mol% of commercially available NHC ligand L1 and 3.0 equiv of AgOAc (in 0.5 mL of hexafluorobenzene at 100 °C under air for 24 h) gave exclusively the cis-diastereoisomer of the desired product in 53% yield (Table 1). In the absence of ligand, only trace amount of product was detected, thus confirming the significant impact of NHC-ligands on the β-C(sp3)–H arylation reaction of piperidine amide 1a. The beneficial effects of Ag(I) salts is also inconsistent with a Pd(0)/Pd(II) redox chemistry, but is consistent with a Pd(II)/Pd(IV) catalytic cycle.3,4 We next performed a systematic screen of 4,5-dihydroimidazolium ligands using these standard conditions. Increasing the steric hindrance on the N-aryl ring improved the yield to 66% (L2). Replacement of the N-aryl with sterically bulky alkyl groups consistently improves the reaction and affords excellent yields with L4, L6 and L7. The significantly lower yield obtained with L8 suggests that the tertiary carbon attached to the nitrogen is required. We also examined imidazolium ligands with similar steric environment. The results with L9–L14 show that imidazolium ligands are inferior to 4,5-dihydroimidazolium ligands for this reaction.

Table 1.

Ligand Screeninga,b,c,

graphic file with name nihms688315f5.jpg
a

Conditions: 0.1 mmol of 1a, 2.0 equiv of 2a, 10 mol% of Pd(TFA)2, 20 mol% of ligand, 3.0 equiv of AgOAc, 0.5 mL of hexafluorobenzene, 100 °C, under air, 24 h.

b

The yield was determined by 1H NMR analysis of the crude product using CH2Br2 as an internal standard.

c

Single cis-diastereoisomer was obtained.

With these optimized reaction conditions in hand, we examined the scope of aryl-iodides (Table 2). Arylation of 1a with a few simple aryl iodides using L4 gave the expected products in excellent yields (3a1–4). Para-methoxylphenyl ioide and 3,4-methylenedioxyiodobenzene are also effective coupling partners affording 3a5 and 3a6 in 98 and 88% yield respectively. However, other aryl iodides, especially the ortho, or meta-substituted aryl iodides (3a7, 3a8), gave moderate yields (~40%) under these initially optimized conditions. We were pleased to find that the use of the less hindered ligand L7 significantly improved the yields in these cases (3a7, 3a8). Aryl-iodides with different protecting groups (TBS, Ac, Boc) are also compatible with this arylation reaction using ligand L7 (3a9–12). Notably, aryl iodides containing ortho-OMe (3a8), and ortho-NHAc (3a12) are especially challenging coupling partners in previous studies.3,4 These results indicate a better match between substrates and ligands can be achieved by tuning the ligand structures. Para-fluoro-, chloro- and bromo-phenyliodides are effective coupling partners (3a13, 3a15, 3a16) while ortho-fluoro-phenyl iodide gave the desired product 3a14 in 40% yield. Other strongly electron-withdrawing groups CF3, -Ac, -COOMe, and -CHO are also tolerated (3a17–21). Bromo, COOMe and CHO are highly useful functional groups for synthetic elaborations. Aryl iodides containing potentially coordinating groups such as phosphate and thioether also afforded synthetically useful yields (3a22, 3a23). A limited number of heteroaryl iodides are also successfully coupled with 1a (3a24–28) to give heterocycles that are potentially medicinally important. However, the strongly coordinating pyridinyl, quinolinyl and pyrazolyl iodides are not compatible with current conditions.

Table 2.

C(sp3)–H Arylationa,b,c

graphic file with name nihms688315f6.jpg
a

Conditions: 0.1 mmol of 1a, 2.0 equiv of 2, 10 mol% of Pd(TFA)2, 20 mol% of L4, 3.0 equiv of AgOAc, 0.5 mL of hexafluorobenzene, 100 °C, under air, 24 h.

b

Isolated yields.

c

Single cis-diastereoisomer was obtained.

d

3.0 equiv of 2 was used, L7 was used, 2.0 equiv of Ag2CO3 was used.

Having established the scope of aryl iodides, we subjected 3- and 4-piperidinecarboxamides 1b and 1c to the standard arylation conditions (Table 3). The arylated products were obtained in 66 and 57% yields respectively as mixtures of cis and trans isomers (3b, 3c). The exclusive regioselectivity observed in 3b appears to indicate that Pd insertion into C-H bonds adjacent to the nitrogen atoms is less favored, which could be due to the known α-effect as the carbon center will be negatively charged during the C–H cleavage step. The use of Troc instead of trifluoroacetyl protecting group did not affect the yield significantly (3d). Interestingly, 2-methyl-3-piperidinecarboxamide gave the arylated trans-isomer 3e selectively in higher yield. The high trans-selectivity can be explained by the 1,3-interaction that significantly increases the steric hindrance if the Pd were to insert into the cis-axial C–H bond (Figure 1). Arylation of 2-pyrrolidinecarboxamide gave the cis-isomer 3f selectively, albeit in low yield. This arylation protocol is also extended to the functionalization of tetrahydropyrans. While, arylation of 3-tetrahydropyrancarboxamide 2g afforded a mixture of the cis and trans products in 72% yield, 4-tetrahydropyrancarboxamide 2h is not as reactive affording the products in low yield (3h). The lower reactivity of 2h is most likely due to bisdentate coordination from the directing group and the 4-oxygen atom which is not possible in 2g due to geometric constraints. Interestingly, arylation of 1,1-dioxohexahydrothiopyran-4-carboxamide 1i also proceeded to give the desired product in 62% yield, with the cis isomer being the major product (3i). The preference for inserting in the cis-axial C–H bonds indicates a strong impact of the large sulfonyl group on the conformation of the six-membered ring (Figure 1).

Table 3.

C(sp3)–H Arylationa,b

graphic file with name nihms688315f7.jpg
a

Conditions: 0.1 mmol of 1, 3.0 equiv of 2a, 10 mol% of Pd(TFA)2, 20 mol% of L7, 2.0 equiv of Ag2CO3, 0.5 mL of hexafluorobenzene, 100 °C, under air, 24 h.

b

Isolated yields.

Figure 1.

Figure 1

Examples of synthetic piperidine and tetrahydropyran drugs

To demonstrate the robustness of this β-C(sp3)–H arylation reaction, we performed of the arylation of 1a on gram scale to form 3a1 in 84% yield (Scheme 1). Since this reaction is compatible with a wide range of solvents including DCE (ClCH2CH2Cl), toluene, EtOAc (see SI), we chose the less expensive solvent DCE to perform the gram scale reaction. Two different protocols are also developed to convert the amide into ester and thioester respectively in one-pot (Scheme 2).

Scheme 1.

Scheme 1

Gram-Scale Synthesis

Scheme 2.

Scheme 2

Deprotection

In summary, NHC ligands were found to promote arylation of β-C(sp3)–H bonds of saturated heterocycles via Pd(II)/Pd(IV) catalysis. Both C-3 and C-4 C–H arylation of piperidines and tetrahydropyrans are enabled by NHC ligands. Further optimization of the ligand structure to broaden the scope of heterocycles is under way in our laboratory.

Supplementary Material

Supp

Figure 2.

Figure 2

Possible Explanation for Diastereoselectivity

Acknowledgments

We gratefully acknowledge The Scripps Research Institute, the NIH (NIGMS, 2R01GM084019), and Vertex Pharmaceuticals for financial support.

Footnotes

Supporting Information Available: Experimental procedures and spectral data for all new compounds (PDF). This material is available free of charge via the Internet at http://pubs.acs.org.

References

  • 1.For selected reviews: Daugulis O, Do HQ, Shabashov D. Acc Chem Res. 2009;42:1074. doi: 10.1021/ar9000058.Jazzar R, Hitce J, Renaudat A, Sofack-Kreutzer J, Baudoin O. Chem Eur J. 2010;16:2654. doi: 10.1002/chem.200902374.Lyons TW, Sanford MS. Chem Rev. 2010;110:1147. doi: 10.1021/cr900184e.Wasa M, Engle KM, Yu JQ. Isr J Chem. 2010;50:605. doi: 10.1002/ijch.201000038.Baudoin O. Chem Soc Rev. 2011;40:4902. doi: 10.1039/c1cs15058h.Guy R, Naoto C. Angew Chem, Int Ed. 2013;52:11726.
  • 2.Giri R, Chen X, Yu JQ. Angew Chem Int Ed. 2005;44:2112. doi: 10.1002/anie.200462884. [DOI] [PubMed] [Google Scholar]
  • 3.(a) Zaitsev VG, Shabashov D, Daugulis O. J Am Chem Soc. 2005;127:13154. doi: 10.1021/ja054549f. [DOI] [PubMed] [Google Scholar]; (b) Feng Y, Chen G. Angew Chem Int Ed. 2010;49:958. doi: 10.1002/anie.200905134. [DOI] [PubMed] [Google Scholar]; (c) Gutekunst WR, Baran PS. J Am Chem Soc. 2011;133:19076. doi: 10.1021/ja209205x. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Tran LD, Daugulis O. Angew Chem, Int Ed. 2012;51:5188. doi: 10.1002/anie.201200731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.(a) Giri R, Maugel N, Li JJ, Wang DH, Breazzano SP, Saunders LB, Yu JQ. J Am Chem Soc. 2007;129:3510. doi: 10.1021/ja0701614. [DOI] [PubMed] [Google Scholar]; (b) Wang DH, Wasa M, Giri R, Yu JQ. J Am Chem Soc. 2008;130:7190. doi: 10.1021/ja801355s. [DOI] [PubMed] [Google Scholar]; (c) Wang DH, Mei TS, Yu JQ. J Am Chem Soc. 2008;130:17676. doi: 10.1021/ja806681z. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Wasa M, Engle KM, Yu JQ. J Am Chem Soc. 2009;131:9886. doi: 10.1021/ja903573p. [DOI] [PMC free article] [PubMed] [Google Scholar]; (e) Wasa M, Worrell BT, Yu JQ. Angew Chem Int Ed. 2010;49:1275. doi: 10.1002/anie.200906104. [DOI] [PMC free article] [PubMed] [Google Scholar]; (f) Engle KM, Thuy-Boun PS, Dang M, Yu JQ. J Am Chem Soc. 2011;133:18183. doi: 10.1021/ja203978r. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.(a) Wasa M, Chan KSL, Zhang XG, He J, Miura M, Yu J-Q. J Am Chem Soc. 2012;134:18570. doi: 10.1021/ja309325e. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) He J, Li S, Deng Y, Fu H, Laforteza BN, Spangler JE, Homs A, Yu JQ. Science. 2014;343:1216. doi: 10.1126/science.1249198. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Li S, Chen G, Feng CG, Gong W, Yu JQ. J Am Chem Soc. 2014;136:5267. doi: 10.1021/ja501689j. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Deng Y, Gong W, He J, Yu JQ. Angew Chem Int Ed. 2014;53:6692. doi: 10.1002/anie.201403878. [DOI] [PMC free article] [PubMed] [Google Scholar]; (e) Zhu RY, He J, Yu JQ. J Am Chem Soc. 2014;136:13194. doi: 10.1021/ja508165a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.For selected reviews: Hillier AC, Grasa GA, Viciu MS, Lee HM, Yang CL, Nolan SP. J Organomet Chem. 2002;653:69.Scott NM, Nolan SP. Eur J Inorg Chem. 2005;10:1815.Kantchev EAB, O’Brien CJ, Organ MG. Angew Chem, Int Ed. 2007;46:2768. doi: 10.1002/anie.200601663.Diez-Gonzalez S, Nolan SP. Coord Chem Rev. 2007;251:874.Marion N, Nolan SP. Acc Chem Res. 2008;41:1440. doi: 10.1021/ar800020y.Würtz S, Glorius F. Acc Chem Res. 2008;41:1523. doi: 10.1021/ar8000876.Fortman GC, Nolan SP. Chem Soc Rev. 2011;40:5151. doi: 10.1039/c1cs15088j.Valente C, Çalimsiz S, Hoi KH, Mallik D, Sayah M, Organ MG. Angew Chem, Int Ed. 2012;51:3314. doi: 10.1002/anie.201106131.Yuan D, Huynh HV. Molecules. 2012;17:2491. doi: 10.3390/molecules17032491.Budagumpi S, Haque RA, Salman AW. Coord Chem Rev. 2012;256:1787.
  • 7.(a) McGrath NA, Brichacek M, Njardarson JT. J Chem Ed. 2010;87:1348. [Google Scholar]; (b) Njardarson Web site. http:/cbc.arizona.edu/njardarson/group.; (c) Meanwell NA. Chem Res Toxicol. 2011;24:1420. doi: 10.1021/tx200211v. [DOI] [PubMed] [Google Scholar]; (d) Lovering F, Bikker J, Humblet C. J Med Chem. 2009;52:6752. doi: 10.1021/jm901241e. [DOI] [PubMed] [Google Scholar]
  • 8.http://thomsonreuters.com/en/products-services/pharma-life-sciences/pharmaceutical-research/integrity.html.
  • 9.Arylation of proline: Affron DP, Davis OA, Bull JA. Org Lett. 2014;16:4956. doi: 10.1021/ol502511g.Feng R, Wang B, Liu Y, Liu Z, Zhang Y. Eur J Org Chem. 2015:142.
  • 10.Arylation of tetrahydrofuran: Parella R, Babu SA. J Org Chem. 2015;80:2339. doi: 10.1021/acs.joc.5b00025.
  • 11.For a single example of alkylation of 2-piperidinecarboxamide substrate: Zhang SY, Li Q, He G, Nack WA, Chen G. J Am Chem Soc. 2013;135:12135. doi: 10.1021/ja406484v.
  • 12.Selected C(3)-H functionalization of piperidines through dehydrogenation: Xia XF, Shu XZ, Ji KG, Yang YF, Shaukat A, Liu XY, Liang YM. J Org Chem. 2010;75:2893. doi: 10.1021/jo100133z.Sundararaju B, Achard M, Sharma GVM, Bruneau C. J Am Chem Soc. 2011;133:10340. doi: 10.1021/ja203875d.Boudiar T, Sahli Z, Sundararaju B, Achard M, Kabouche Z, Doucet H, Bruneau C. J Org Chem. 2012;77:3674. doi: 10.1021/jo300237s.Yuan K, Jiang F, Sahli Z, Achard M, Roisnel T, Bruneau C. Angew Chem Int Ed. 2012;51:8876. doi: 10.1002/anie.201204582.Takasu N, Oisaki K, Kanai M. Org Lett. 2013;15:1918. doi: 10.1021/ol400568u.Millet A, Larini P, Clot E, Baudoin O. Chem Sci. 2013;4:2241.Chen W, Kang Y, Wilde RG, Seidel D. Angew Chem Int Ed. 2014;53:5179. doi: 10.1002/anie.201311165.
  • 13.Selected C(2)-H arylation: Beak P, Kerrick ST, Wu S, Chu J. J Am Chem Soc. 1994;116:3231.Dieter RK, Li S. Tetrahedron Lett. 1995;36:3613.Dieter RK, Li S. J Org Chem. 1997;62:7726.Li Z, Li CJ. J Am Chem Soc. 2005;127:6968. doi: 10.1021/ja0516054.Campos KR, Klapars A, Waldman JH, Dormer PG, Chen CY. J Am Chem Soc. 2006;128:3538. doi: 10.1021/ja0605265.Pastine SJ, Gribkov DV, Sames D. J Am Chem Soc. 2006;128:14220. doi: 10.1021/ja064481j.Klapars A, Campos KR, Waldman JH, Zewge D, Dormer PG, Chen C. J Org Chem. 2008;73:4986. doi: 10.1021/jo8006804.Ohta M, Quick MP, Yamaguchi J, Wünsch B, Itami K. Chem Asian J. 2009;4:1416. doi: 10.1002/asia.200900157.Yoshikai N, Mieczkowski A, Matsumoto A, Ilies L, Nakamura E. J Am Chem Soc. 2010;132:5568. doi: 10.1021/ja100651t.McNally A, Prier CK, MacMillan DWC. Science. 2011;334:1114. doi: 10.1126/science.1213920.Jin J, MacMillan DWC. Angew Chem Int Ed. 2014;54:1565.
  • 14.(a) Nakanishi M, Katayev D, Besnard C, Kündig EP. Angew Chem Int Ed. 2011;50:7438. doi: 10.1002/anie.201102639. [DOI] [PubMed] [Google Scholar]; (b) Katayev D, Nakanishi M, Buergi T, Kündig EP. Chem Sci. 2012;3:1422. [Google Scholar]; (c) Larionov E, Nakanishi M, Katayev D, Besnard C, Kündig EP. Chem Sci. 2013;4:1995. [Google Scholar]; (d) Katayev D, Larionov E, Nakanishi M, Besnard C, Kündig EP. Chem Eur J. 2014;20:15021. doi: 10.1002/chem.201403985. [DOI] [PubMed] [Google Scholar]
  • 15.For selected examples of Pd(0)/NHC catalyzed sp2 C – H arylation: Gürbüz N, Özdemir I, Cetinkaya B. Tetrahedron Lett. 2005;46:2273.Campeau LC, Thansandote P, Fagnou K. Org Lett. 2005;7:1857. doi: 10.1021/ol050501v.Ghosh D, Lee HM. Org Lett. 2012;14:5534. doi: 10.1021/ol302635e.Dooley JD, Chidipudi SR, Lam HW. J Am Chem Soc. 2013;135:10829. doi: 10.1021/ja404867k.Gu Z-S, Chen W-X, Shao L-X. J Org Chem. 2014;79:5806. doi: 10.1021/jo5010058.Shen XB, Zhang Y, Chen WX, Xiao ZK, Hu TT, Shao LX. Org Lett. 2014;16:1984. doi: 10.1021/ol500531m.
  • 16.For NHC/Pd(0)-catalyzed C(sp3)–H alkynylation: He J, Wasa M, Chan KSL, Yu JQ. J Am Chem Soc. 2013;135:3387. doi: 10.1021/ja400648w.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supp

RESOURCES